Brief: Corline Biomedical Enters Term Sheet Regarding Additional Medical Applications In USA
Aug 2 (Reuters) - Corline Biomedical AB CLBIO.ST :
* ENTERS INTO TERM SHEET REGARDING ADDITIONAL MEDICAL
APPLICATIONS
IN USA
* COMMON GOAL IS FOR CUSTOMER AND CORLINE TO TRANSFORM TERM
SHEET
INTO A BINDING AGREEMENT DURING Q3 2021
* AFTER COMPLETED DEVELOPMENT AND UPSCALING PERIOD, THE
APPLICATION IS EXPECTED TO BE ABLE TO GENERATE REVENUE FOR
CORLINE OF MORE THAN SEK 50 MLN ANNUALLY
Source text for Eikon: ID:nGNE4V8rKc
Further company coverage: CLBIO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Corline Biomedical AB
See all newsBrief: Corline Biomedical Expectes Positive EBITDA In 2027
Brief: Corline Biomedical: Canada To Grant Kardium Up To C$31.25 Mln For Manufacturing Capacity Expansion
Brief: Corline Biomedical Q2 Net Sales Amount To SEK 4.7 Million
Brief: Corline Biomedical Partner Kardium Receives Approval For Globe Pulsed Field System In Canada
Brief: Corline Biomedical Q1 Result After Financial Items At SEK -2.5 Mln